Hyderabad : Yashoda Hospitals, Hitec City, through its Academy for Advanced Pulmonary Education & Research (AAPER), successfully conducted the Bronchiectasis Preceptorship Program – Real-Life, Case-Based Interactive Learning, bringing together leading pulmonologists, radiologists, geneticists, physiotherapists, and respiratory medicine experts from across India. The one-day academic program served as a comprehensive platform for clinicians to exchange knowledge on the latest advances in the diagnosis, phenotyping, precision medicine, and multidisciplinary management of bronchiectasis. The event featured distinguished faculty from premier institutions including AIIMS Rishikesh, PGIMER Chandigarh, CMC Vellore, NIMS Hyderabad, Apollo Hospitals, and several other renowned centres of excellence.
The scientific sessions covered key topics such as radiological phenotyping, precision medicine, cystic fibrosis, primary ciliary dyskinesia, allergic bronchopulmonary aspergillosis (ABPA), post-tuberculosis bronchiectasis, long-term antibiotic strategies, management of Pseudomonas infections, and the role of mucoactive therapies. Interactive case-based discussions enabled participants to translate evidence into real-world clinical practice, while expert-led panel discussions highlighted the importance of identifying the underlying cause of bronchiectasis to enable personalised treatment and improve long-term patient outcomes.
A major highlight of the program was the series of hands-on workshops, where delegates received practical training in airway clearance techniques, airway clearance devices, diagnostic testing for cystic fibrosis and primary ciliary dyskinesia, as well as genetic testing and counselling. These skill-based sessions reinforced the importance of a multidisciplinary approach involving pulmonologists, physiotherapists, laboratory specialists, and genetic experts in delivering comprehensive care for patients with bronchiectasis.
Speaking on the occasion, Dr. V. Nagarjuna Maturu, Senior Consultant & Clinical Director – Clinical and Interventional Pulmonology, Yashoda Hospitals, Hitec City, and Program Director, said, “Bronchiectasis remains an under-recognised yet increasingly important chronic respiratory disease in India, with causes and treatment needs that vary significantly from one patient to another. Through this preceptorship, our objective was to equip clinicians with practical, evidence-based approaches to identify the underlying aetiology, adopt precision medicine principles, and strengthen multidisciplinary collaboration. By combining expert-led discussions with hands-on learning, we hope to improve early diagnosis, optimise patient care, and ultimately enhance the quality of life for individuals living with bronchiectasis.”